- Published at
- by manilatimes.net
mixed
mixed
News for Travere Therapeutics, Inc. (TVTX)
- Published at
- by manilatimes.net
mixedmixed- Published at
- by gurufocus.com
positivepositiveTravere Therapeutics Inc (TVTX) Announces Participation in Upcoming Investor Conferences
Summary Travere Therapeutics Inc (TVTX), a biopharmaceutical company dedicated to developing therapies for rare diseases, announced on February 24, 2025, that i- Published at
- by gurufocus.com
positivepositiveTravere Therapeutics to Participate at Upcoming Investor Conferences
SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc. ( TVTX) today announced that company management will participate in the following upco- Published at
- by insidermonkey.com
positivepositiveTravere Therapeutics, Inc. (TVTX): the Best Performing Pharma Stock So Far in 2025
We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a look at where Travere Therapeutics, Inc.- Published at
- by insidermonkey.com
positivepositive10 Best Performing Pharma Stocks So Far in 2025
On February 20, Jared Holz, Mizuho healthcare sector strategist, appeared on 'Squawk Box' to discuss the potential challenges and opportunities the pharmaceutical industry may face under the new Trump...- Published at
- by gurufocus.com
positivepositiveTravere Therapeutics Inc (TVTX) Reports Strong 2024 Financial Results and Strategic Updates
Travere Therapeutics Inc (TVTX) has released its financial results for the fourth quarter and full year of 2024, alongside a corporate update. The company repor- Published at
- by seekingalpha.com
positivepositiveTravere Therapeutics, Inc. (TVTX) Q4 2024 Earnings Call Transcript
Travere Therapeutics, Inc. (NASDAQ:TVTX) Q4 2024 Earnings Conference Call February 20, 2025 4:30 PM ETCompany ParticipantsVictoria Prescott - Manager of...- Published at
- by zacks.com
positivepositiveTravere Therapeutics (TVTX) Reports Q4 Loss, Tops Revenue Estimates
Travere (TVTX) delivered earnings and revenue surprises of -25.86% and 1.84%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?- Published at
- by manilatimes.net
positivepositive- Published at
- by gurufocus.com
positivepositiveARMISTICE CAPITAL, LLC Reduces Stake in Travere Therapeutics Inc
Transaction Overview On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a strategic transaction involving Travere Therapeutics Inc (TVTX)- Published at
- by gurufocus.com
positivepositiveARMISTICE CAPITAL, LLC Acquires Significant Stake in Sphere 3D Corp
On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a notable transaction by acquiring 2,583,718 shares of Sphere 3D Corp. This acquisitio- Published at
- by gurufocus.com
positivepositiveARMISTICE CAPITAL, LLC Increases Stake in Ekso Bionics Holdings Inc
Transaction Overview On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a strategic transaction involving Ekso Bionics Holdings Inc. The- Published at
- by gurufocus.com
positivepositiveARMISTICE CAPITAL, LLC Acquires Significant Stake in Edible Garden AG Inc
On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a notable transaction by acquiring 1,624,837 shares of Edible Garden AG Inc (EDBL) at- Published at
- by gurufocus.com
positivepositiveArmistice Capital, LLC Reduces Stake in Danimer Scientific Inc
On December 31, 2024, Armistice Capital, LLC executed a significant transaction involving Danimer Scientific Inc (DNMR). The firm reduced its holdings by 97,939- Published at
- by gurufocus.com
positivepositiveARMISTICE CAPITAL, LLC Acquires Additional Shares in Cosmos Health Inc
On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a significant transaction involving Cosmos Health Inc (COSM). The firm added 849,163 s- Published at
- by gurufocus.com
positivepositiveARMISTICE CAPITAL, LLC Increases Stake in Iveda Solutions Inc
On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a strategic stock transaction involving Iveda Solutions Inc. The firm added 9,603 shar- Published at
- by gurufocus.com
positivepositiveARMISTICE CAPITAL, LLC Increases Stake in Eledon Pharmaceuticals Inc
On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) made a significant move by acquiring an additional 773,553 shares of Eledon Pharmaceuticals Inc- Published at
- by gurufocus.com
positivepositiveARMISTICE CAPITAL, LLC Reduces Stake in Clene Inc: Analyzing the Implications
On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio), a notable investment firm, executed a significant transaction involving Clene Inc (CLNN). The- Published at
- by gurufocus.com
positivepositiveARMISTICE CAPITAL, LLC Reduces Stake in Can Fite Biofarma Ltd
Overview of the Recent Transaction On December 31, 2024, ARMISTICE CAPITAL, LLC (Trades, Portfolio) executed a significant transaction involving Can Fite Biofar